Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
Euglycemic diabetic ketoacidosis (EDKA) was considered a rare condition with its specific definition and precipitating factors. However, with the wide use of sodium glucose cotransporter 2 (SGLT-2) inhibitors, the newest class of antidiabetic agents, EDKA has come back into the spotlight. Relevant c...
Saved in:
Main Authors: | Xiaofang Yu, Saifei Zhang, Long Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2018/7074868 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication
by: Asma Abu-Abed Abdin, et al.
Published: (2016-01-01) -
Euglycemic Diabetic Ketoacidosis in a Pregnant Patient on Insulin Pump Therapy
by: Hesham Yasin, MD, et al.
Published: (2025-01-01) -
Sodium-Glucose Transport Protein 2 Inhibitors Association with Euglycemic Diabetic Ketoacidosis
by: Caroline Wojtas, et al.
Published: (2023-01-01) -
Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report
by: Lulu Chu, et al.
Published: (2025-01-01) -
A Case of Euglycemic Ketoacidosis Secondary to Continuous Renal Replacement Therapy
by: Evan J. Chen, et al.
Published: (2025-01-01)